REMEDY : BNSSG referral pathways & Joint Formulary


Home > Formulary : Adult > Chapters > 2. Cardiovascular System >

BNSSG Adult Joint Formulary

2.9 Vascular disease

Last edited: 01-02-2024

First line drugs Second line drugs Specialist drugs Secondary care drugs

Peripheral vascular disease

 

5HT2 Receptor Antagonists

Specific Indication: (TLS Blue)

Naftidrofuryl oxalate

  • NICE TA223 For the treatment of intermittent claudication in people with peripheral arterial disease 

 

2.9.1 Vein malformations

Recommended: (TLS Red)

Ethanolamine oleate

Sodium tetradecyl sulphate

Bleomycin

 

2.9.2 Granulomatosis

Granulomatosis

Avacopan (TLS Red)

  • NICE TA825 Avacopan for treating severe active granulomatosis with polyangiitis or microscopic polyangiitis

 

Contact Us

Got a question or comment about the Joint Formulary? 

Please use the email address below to contact us and we will endeavour to respond within 2 working days.